Attenuation of liver normothermic ischemia-reperfusion injury by preservation of mitochondrial functions with S-15176, a potent trimetazidine derivative
A. Elimadi et al., Attenuation of liver normothermic ischemia-reperfusion injury by preservation of mitochondrial functions with S-15176, a potent trimetazidine derivative, BIOCH PHARM, 62(4), 2001, pp. 509-516
We investigated the antiischemic properties of a new compound, S-15176, in
an experimental model of rat liver subjected to 120-min normothermic ischem
ia followed by 30-min reperfusion. Rats were divided into groups, pretreate
d with different doses of S-15176 (1.25, 2.5, 5 and 10 mg/kg/day by intramu
scular injection) or solvent alone, and subjected to the ischemia-reperfusi
on process. Another group served as the sham-operated controls. Ischemia-re
perfusion induced huge alterations of hepatocyte functions, namely, a decre
ase in ATP content and bile flow, and membrane leakage of alanine aminotran
sferase (ALAT) and aspartate aminotransferase (ASAT). These effects were as
sociated with alterations in mitochondrial functions characterized by (1) a
decrease in ATP synthesis, (2) a decrease in NAD(P)H levels and mitochondr
ial membrane potential, and (3) an increase in mitochondrial swelling refle
cting the generation of permeability transition. Pretreatment of rats with
S-15176 alleviated these deleterious ischemia-reperfusion effects at both t
he cellular and mitochondrial levels in a dose-dependent manner. The protec
tion of mitochondrial functions was almost complete at a dosage of 10 mg/kg
/day. In addition, in vitro, S-15176 totally abolished the swelling of isol
ated mitochondria induced by a calcium overload with an IC50 value of 10 mu
M These data demonstrate that S-15176 protects mitochondria against the del
eterious effects of ischemia-reperfusion and suggest that this protective e
ffect could be related to the inhibition of the mitochondrial permeability
transition. (C) 2001 Elsevier Science Inc. All rights reserved.